Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.

Saved in:
Bibliographic Details
Title: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.
Authors: Nakamura B; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Senguttuvan R; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Ruel NH; Department of Computation and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, United States., Frankel PH; Department of Computation and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, United States., Yost SE; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States., Cole S; Clinical Protocol Development, City of Hope National Medical Center, Duarte, CA, United States., Chang S; Department of Pathology, City of Hope National Medical Center, Duarte, CA, United States., Jung A; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States., Eng M; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Tinsley R; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Stewart D; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States., Wang E; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States., Cohen J; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Villella J; Department of Surgery, Northwell Health, New York, NY, United States., Whelan RL; Department of Surgery, Northwell Health, New York, NY, United States., Merchea A; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, United States., DePeralta DK; Department of Surgery, Northwell Health, New York, NY, United States., Cristea M; Regeneron Pharmaceuticals, Tarrytown, NY, United States., Wakabayashi MT; Regeneron Pharmaceuticals, Tarrytown, NY, United States., Raoof M; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States., Dellinger TH; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2024 Aug 01; Vol. 14, pp. 1404936. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39148906
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakamura+B%22">Nakamura B</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Senguttuvan+R%22">Senguttuvan R</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ruel+NH%22">Ruel NH</searchLink>; Department of Computation and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Frankel+PH%22">Frankel PH</searchLink>; Department of Computation and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yost+SE%22">Yost SE</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cole+S%22">Cole S</searchLink>; Clinical Protocol Development, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Chang+S%22">Chang S</searchLink>; Department of Pathology, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Jung+A%22">Jung A</searchLink>; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Eng+M%22">Eng M</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Tinsley+R%22">Tinsley R</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Stewart+D%22">Stewart D</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cohen+J%22">Cohen J</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Villella+J%22">Villella J</searchLink>; Department of Surgery, Northwell Health, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Whelan+RL%22">Whelan RL</searchLink>; Department of Surgery, Northwell Health, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Merchea+A%22">Merchea A</searchLink>; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, United States.<br /><searchLink fieldCode="AU" term="%22DePeralta+DK%22">DePeralta DK</searchLink>; Department of Surgery, Northwell Health, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Cristea+M%22">Cristea M</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Wakabayashi+MT%22">Wakabayashi MT</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Raoof+M%22">Raoof M</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Dellinger+TH%22">Dellinger TH</searchLink>; Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Aug 01; Vol. 14, pp. 1404936. <i>Date of Electronic Publication: </i>2024 Aug 01 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39148906
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1404936
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1404936
    Titles:
      – TitleFull: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakamura B
      – PersonEntity:
          Name:
            NameFull: Senguttuvan R
      – PersonEntity:
          Name:
            NameFull: Ruel NH
      – PersonEntity:
          Name:
            NameFull: Frankel PH
      – PersonEntity:
          Name:
            NameFull: Yost SE
      – PersonEntity:
          Name:
            NameFull: Cole S
      – PersonEntity:
          Name:
            NameFull: Chang S
      – PersonEntity:
          Name:
            NameFull: Jung A
      – PersonEntity:
          Name:
            NameFull: Eng M
      – PersonEntity:
          Name:
            NameFull: Tinsley R
      – PersonEntity:
          Name:
            NameFull: Stewart D
      – PersonEntity:
          Name:
            NameFull: Wang E
      – PersonEntity:
          Name:
            NameFull: Cohen J
      – PersonEntity:
          Name:
            NameFull: Villella J
      – PersonEntity:
          Name:
            NameFull: Whelan RL
      – PersonEntity:
          Name:
            NameFull: Merchea A
      – PersonEntity:
          Name:
            NameFull: DePeralta DK
      – PersonEntity:
          Name:
            NameFull: Cristea M
      – PersonEntity:
          Name:
            NameFull: Wakabayashi MT
      – PersonEntity:
          Name:
            NameFull: Raoof M
      – PersonEntity:
          Name:
            NameFull: Dellinger TH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1